About Aoli Biology
Aoli Biology was founded in 2022 as a provider of development services for oral biopharmaceuticals. Operations are centered on biopharmaceutical research and formulation, with a focus on oral delivery systems. Services include preclinical development, testing, and optimization for biopharma clients. The company operates in the biotechnology sector, supporting drug innovation without specified geographic locations. Domain presence is maintained at aolibiology.tcc.mode for online accessibility.
-
Sectors
Business ServicesHealthcare
-
Phone
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Cowin Capital
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aoli Biology
Investors in Aoli Biology
Aoli Biology has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Cowin Capital, Leaguer and unknown.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Leaguer is engaged in technology transfer and innovation services.
|
Locked | Locked | Locked |
Investor details for Aoli Biology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aoli Biology
Investment portfolio details for Aoli Biology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aoli Biology
Detailed financials for Aoli Biology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aoli Biology Comparisons
Peer comparison for Aoli Biology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aoli Biology
Detailed competitors of Aoli Biology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aoli Biology
Complete news archive for Aoli Biology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aoli Biology
Aoli Biology was founded in 2022.
Aoli Biology was founded in 2022 as a provider of development services for oral biopharmaceuticals. Operations are centered on biopharmaceutical research and formulation, with a focus on oral delivery systems. Services include preclinical development, testing, and optimization for biopharma clients. The company operates in the biotechnology sector, supporting drug innovation without specified geographic locations. Domain presence is maintained at aolibiology.tcc.mode for online accessibility.
Aoli Biology has 3 investors. Key investors include Cowin Capital, Leaguer, and unknown.